2014-2018 World Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

2014-2018 World Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

Category : Diagnostic and Biotech
Published On : November  2014
Pages : 775



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

2014-2018 World Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

This new seven-country study from Venture Planning Group contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

Business and technological trends in major markets
Five-year test volume and sales forecasts
Market shares of leading competitors
Feature comparison of major analyzers
Strategic profiles of leading market players and start-up firms developing innovative products
Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

France
Germany
Italy
Japan
Spain
UK
USA
Worldwide Market Overview

Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment.
Five-year test volume and sales projections by country.
Market Segmentation Analysis

Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.
Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.
A comprehensive analysis of the sequencing market by country and laboratory segment.
Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.
Product/Technology Review

Comparison of leading infectious disease molecular diagnostic analyzers.
Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.
Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Eiken
Enzo
Exact Sciences
Fujirebio/Innogenetics
Grifols
Hologic/Gen-Probe
Illumina
Kreatech
Li-Cor Biosciences
Life Technologies/Thermo Fisher
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.
Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially significant market appeal during the next five years.
Design criteria for new products.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

image
Can't read the image ? refresh here.


Enquiry Before Buy
image
Can´t read the image ? refresh here.